LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Operating Income

As of the most recent data (March 2024), LSBPW shows a operating income of $-200M. That compares with $-8.2M in the prior-year period — down 2318.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSBPW's operating income is now $-200M (was $-8.2M) — a 2318.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

Tracking LSBPW's operating income over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $-200M That compares with $-8.2M in the prior-year period — down 2318.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-200M) with ownership activity and broader fundamentals.